{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:00:04Z","timestamp":1793412004256,"version":"4.5.0"},"reference-count":24,"publisher":"Japan Neurosurgical Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2023,8,15]]},"DOI":"10.2176\/jns-nmc.2023-0041","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T22:13:57Z","timestamp":1683756837000},"page":"334-342","source":"Crossref","is-referenced-by-count":7,"title":["Neuronal Loss in the Bilateral Medial Frontal Lobe Revealed by &lt;sup&gt;123&lt;\/sup&gt;I-iomazenil Single-photon Emission Computed Tomography in Patients with Moyamoya Disease: The First Report from Cognitive Dysfunction Survey of Japanese Patients with Moyamoya Disease (COSMO-Japan Study)"],"prefix":"10.2176","volume":"63","author":[{"given":"Takayuki","family":"KIKUCHI","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Kyoto University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"TAKAGI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokushima University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoji","family":"NAKAGAWARA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"UENO","sequence":"additional","affiliation":[{"name":"Integrated Clinical Education Center, Kyoto University Hospital"},{"name":"Department of Psychiatry, Kyoto University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"UBUKATA","sequence":"additional","affiliation":[{"name":"Medical Innovation Center, Kyoto University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohiro","family":"HOUKIN","sequence":"additional","affiliation":[{"name":"Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"ARAKI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun C","family":"TAKAHASHI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"NAKASE","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nara Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"MURAI","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Kyoto University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"MIYAMOTO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kyoto University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"COSMO-Japan Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kuroda S, Houkin K: Moyamoya disease: current concepts and future perspectives. <i>Lancet Neurol<\/i> 7: 1056-1066, 2008","DOI":"10.1016\/S1474-4422(08)70240-0"},{"key":"2","unstructured":"2) Miyamoto S, Yoshimoto T, Hashimoto N, et al.: Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. <i>Stroke<\/i> 45: 1415-1421, 2014"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Calviere L, Ssi Yan Kai G, Catalaa I, Marlats F, Bonneville F, Larrue V: Executive dysfunction in adults with moyamoya disease is associated with increased diffusion in frontal white matter. <i>J Neurol Neurosurg Psychiatry<\/i> 83: 591-593, 2012","DOI":"10.1136\/jnnp-2011-301388"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Roder C, Haas P, Fudali M, et al.: Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H215O PET. <i>Neurosurg Rev<\/i> 43: 1615-1622, 2020","DOI":"10.1007\/s10143-019-01192-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Nakamizo A, Kikkawa Y, Hiwatashi A, Matsushima T, Sasaki T: Executive function and diffusion in frontal white matter of adults with moyamoya disease. <i>J Stroke Cerebrovasc Dis<\/i> 23: 457-461, 2014","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.03.022"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kazumata K, Tha KK, Narita H, et al.: Chronic ischemia alters brain microstructural integrity and cognitive performance in adult Mmoyamoya disease. <i>Stroke<\/i> 46: 354-360, 2015","DOI":"10.1161\/STROKEAHA.114.007407"},{"key":"7","unstructured":"7) Hatazawa J, Satoh T, Shimosegawa E, et al.: Evaluation of cerebral infarction with iodine 123-iomazenil SPECT. <i>J Nucl Med<\/i> 36: 2154-2161, 1995"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nakagawara J, Osato T, Kamiyama K, et al.: Diagnostic imaging of higher brain dysfunction in patients with adult moyamoya disease using statistical imaging analysis for [123]iomazenil single photon emission computed tomography. <i>Neurol Med Chir (Tokyo)<\/i> 52: 318-326, 2012","DOI":"10.2176\/nmc.52.318"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Takagi Y, Miyamoto S, COSMO-Japan Study Group: Cognitive dysfunction survey of the Japanese patients with Moyamoya disease (COSMO-JAPAN study): study protocol. <i>Neurol Med Chir (Tokyo)<\/i> 55: 199-203, 2015","DOI":"10.2176\/nmc.ra.2014-0326"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Fujimura M, Tominaga T: Diagnosis of moyamoya disease: international standard and regional differences. <i>Neurol Med Chir (Tokyo)<\/i> 55: 189-193, 2015","DOI":"10.2176\/nmc.ra.2014-0307"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Division of mental health and prevention of substance abuse WHO: WHOQOL user manual 2012 version. 2012doi:10.4091\/iken1991.9.1_123","DOI":"10.4091\/iken1991.9.1_123"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Iida H, Nakagawara J, Hayashida K, et al.: Multicenter evaluation of a standardized protocol for rest and acetazolamide cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine. <i>J Nucl Med<\/i> 51: 1624-1631, 2010","DOI":"10.2967\/jnumed.110.078352"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kim KM, Watabe H, Hayashi T, et al.: Quantitative mapping of basal and vasareactive cerebral blood flow using split-dose 123I-iodoamphetamine and single photon emission computed tomography. <i>Neuroimage<\/i> 33: 1126-1135, 2006","DOI":"10.1016\/j.neuroimage.2006.06.064"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Buchert R, Kluge A, Tossici-Bolt L, et al.: Reduction in camera-specific variability in [ (123) I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls. <i>Eur J Nucl Med Mol Imaging<\/i> 43: 1323-1336, 2016","DOI":"10.1007\/s00259-016-3309-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kim KM, Watabe H, Shidahara M, Ishida Y, Iida H: SPECT collimator dependency of scatter and validation of transmission-dependent scatter compensation methodologies. <i>IEEE Trans Nucl Sci<\/i> 48: 689-696, 2001","DOI":"10.1109\/23.940148"},{"key":"16","unstructured":"16) Kim KM, Varrone A, Watabe H, et al.: Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activities. <i>J Nucl Med<\/i> 44: 512-519, 2003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Yamauchi M, Imabayashi E, Matsuda H, et al.: Quantitative assessment of rest and acetazolamide CBF using quantitative SPECT reconstruction and sequential administration of (123) I-iodoamphetamine: comparison among data acquired at three institutions. <i>Ann Nucl Med<\/i> 28: 836-850, 2014","DOI":"10.1007\/s12149-014-0879-9"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Iida H, Hori Y, Ishida K, et al.: Three-dimensional brain phantom containing bone and grey matter structures with a realistic head contour. <i>Ann Nucl Med<\/i> 27: 25-36, 2013","DOI":"10.1007\/s12149-012-0655-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Skevington SM, Lotfy M, O&apos;Connell KA, WHOQOL Group: The World Health Organization&apos;s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. <i>Qual Life Res<\/i> 13: 299-310, 2004","DOI":"10.1023\/B:QURE.0000018486.91360.00"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Funaki T, Takahashi JC, Takagi Y, et al.: Impact of posterior cerebral artery involvement on long-term clinical and social outcome of pediatric moyamoya disease. <i>J Neurosurg Pediatr<\/i> 12: 626-632, 2013","DOI":"10.3171\/2013.9.PEDS13111"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Shi Z, Wen YJ, Huang Z, Yu LB, Zhang D: Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes. <i>Stroke Vasc Neurol<\/i> 5: 86-96, 2020","DOI":"10.1136\/svn-2019-000309"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Festa JR, Schwarz LR, Pliskin N, et al.: Neurocognitive dysfunction in adult moyamoya disease. <i>J Neurol<\/i> 257: 806-815, 2010","DOI":"10.1007\/s00415-009-5424-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Yasuda S, Katakura Y, Kubo Y, et al.: Recovery of cortical neurotransmitter receptor function and its impact on cognitive improvement after indirect revascularization surgery alone for adult patients with ischemic moyamoya disease: 123I-Iomazenil single-photon emission computed tomography study. <i>World Neurosurg<\/i> 164: e1135-e1142, 2022","DOI":"10.1016\/j.wneu.2022.05.118"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Yamasaki M, Yoshioka H, Kanemaru K, et al.: Detection of transient increase of cerebral blood flow and reversible neuronal dysfunction by iodine-123-iomazenil single photon emission computed tomography after cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease. <i>World Neurosurg<\/i> 141: 335-338, 2020","DOI":"10.1016\/j.wneu.2020.06.014"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/63\/8\/63_2023-0041\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:31:15Z","timestamp":1715574675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/63\/8\/63_2023-0041\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2023-0041","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"article-number":"2023-0041"}}